Similar articles for PMID: 25107559

Year	Number of Results
1981	1
1985	1
1986	1
1992	1
1997	1
2000	1
2003	1
2004	1
2005	4
2006	3
2007	4
2008	5
2009	4
2010	5
2011	9
2012	13
2013	12
2014	23
2015	39
2016	51
2017	56
2018	38
2019	22
2020	23
2021	19
2022	22
2023	8
2024	0

1

TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.

Raaschou P, Frisell T, Askling J; ARTIS Study Group. Raaschou P, et al. Ann Rheum Dis. 2015 Dec;74(12):2137-43. doi: 10.1136/annrheumdis-2014-205745. Epub 2014 Aug 8. Ann Rheum Dis. 2015. PMID: 25107559

2

One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.

Lim CH, Lin CH, Chen DY, Chen YM, Chao WC, Liao TL, Chen HH. Lim CH, et al. PLoS One. 2016 Nov 10;11(11):e0166339. doi: 10.1371/journal.pone.0166339. eCollection 2016. PLoS One. 2016. PMID: 27832150 Free PMC article.

3

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Mercer LK, Galloway JB, Lunt M, Davies R, Low AL, Dixon WG, Watson KD; BSRBR Control Centre Consortium; Symmons DP, Hyrich KL. Mercer LK, et al. Ann Rheum Dis. 2017 Mar;76(3):497-503. doi: 10.1136/annrheumdis-2016-209389. Epub 2016 Aug 8. Ann Rheum Dis. 2017. PMID: 27502891 Free PMC article.

4

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L. Askling J, et al. Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941. Arthritis Rheum. 2009. PMID: 19877027 Free article.

5

Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden.

Wadström H, Frisell T, Sparén P, Askling J; ARTIS study group. Wadström H, et al. Ann Rheum Dis. 2016 Jul;75(7):1272-8. doi: 10.1136/annrheumdis-2015-208263. Epub 2016 Jan 11. Ann Rheum Dis. 2016. PMID: 26755797

6

Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.

Raaschou P, Simard JF, Neovius M, Askling J; Anti-Rheumatic Therapy in Sweden Study Group. Raaschou P, et al. Arthritis Rheum. 2011 Jul;63(7):1812-22. doi: 10.1002/art.30247. Arthritis Rheum. 2011. PMID: 21305513 Free article.

7

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.

Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, Feltelius N, Hetland ML, Askling J; ARTIS Study Group, For the DANBIO Study Group. Hellgren K, et al. Ann Rheum Dis. 2017 Jan;76(1):105-111. doi: 10.1136/annrheumdis-2016-209270. Epub 2016 May 4. Ann Rheum Dis. 2017. PMID: 27147709

8

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study.

Ljung L, Askling J, Rantapää-Dahlqvist S, Jacobsson L; ARTIS Study Group. Ljung L, et al. Arthritis Res Ther. 2014 Jun 18;16(3):R127. doi: 10.1186/ar4584. Arthritis Res Ther. 2014. PMID: 24941916 Free PMC article.

9

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Mercer LK, Lunt M, Low AL, Dixon WG, Watson KD, Symmons DP, Hyrich KL; BSRBR Control Centre Consortium. Mercer LK, et al. Ann Rheum Dis. 2015 Jun;74(6):1087-93. doi: 10.1136/annrheumdis-2013-204851. Epub 2014 Mar 31. Ann Rheum Dis. 2015. PMID: 24685910 Free PMC article.

10

Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.

Simard JF, Neovius M, Askling J; ARTIS Study Group. Simard JF, et al. Arthritis Rheum. 2012 Nov;64(11):3502-10. doi: 10.1002/art.34582. Arthritis Rheum. 2012. PMID: 22886739 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

310 results

Results by year